Viewing Study NCT02055820


Ignite Creation Date: 2025-12-25 @ 4:08 AM
Ignite Modification Date: 2026-02-21 @ 3:12 PM
Study NCT ID: NCT02055820
Status: COMPLETED
Last Update Posted: 2020-06-11
First Post: 2014-02-04
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Study Evaluating the Safety, Efficacy and Pharmacokinetics of Venetoclax Combined With Chemotherapy in Participants With B-Cell Non-Hodgkin's Lymphoma (NHL) and DLBCL
Sponsor: Hoffmann-La Roche
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Lymphoma, Non-Hodgkin View
Keywords: